Analysis of a multicenter, prospective non-interventional study of chemotherapy in elderly patients with biliary tract cancer (JON2104-B)

Analysis of a multicenter, prospective non-interventional study of chemotherapy in elderly patients with biliary tract cancer (JON2104-B) - Analysis of a multicenter, prospective non-interventional study of chemotherapy in elderly patients with biliary tract cancer (JON2104-B)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045156

Enrollment

300

Registered

2021-08-16

Start date

2021-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Aged 70 years or older 2) Clinically and radiologically diagnosed as biliary tract cancer (carcinoma of perihilar bile duct, distal extrahepatic bile duct, gallbladder, ampulla of Vater and intrahepatic bile duct). 3) Pathologically diagnosed adenocarcinoma or adenosquamous carcinoma 4) Unresectable or recurrent biliary tract cancer 5) Scheduled to receive chemotherapy with GC, GS, GCS, GEM, or S-1* 6) No previous radiation therapy or chemotherapy for biliary tract cancer 7) Capable of assessing geriatric assessment (G8, IADL) 8) Written informed consent 9) No malignancy under treatment (prostate and breast cancers treated only with endocrine therapy are eligible). *GC (gemcitabine + cisplatin), GS (gemcitabine + S-1), GCS (gemcitabine + cisplatin + S-1), GEM (gemcitabine)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactKohei Nakachi

Tochigi Cancer Center Medical Oncology

knakachi@tochigi-cc.jp028-658-5151

Outcome results